This paper examines the effect of the 1984 Hatch-Waxman Act and its 2003 amendment - the Medicare Prescription Drug, Improvement, and Modernization Act - on the level of innovation in pharmaceutical firms. In part, the purpose of these policies was to balance ... ...

请注册登录后继续浏览